Number-Based Approach to Insulin Taxonomy
- PMID: 26350081
- PMCID: PMC4674470
- DOI: 10.1007/s13300-015-0129-8
Number-Based Approach to Insulin Taxonomy
Abstract
This article describes a number-based system for the classification of insulin regimes. It utilizes a patient-centered variable (number of injections per day) and pharmacokinetic/dynamic characteristics to craft a taxonomic system that is able to incorporate all available insulin preparations and coformulations. This framework of systematics is robust enough to include various molecules that have been recently developed. It serves to enhance understanding of the subject, and facilitates the practical or clinical usage of theoretical knowledge. We propose that number-based insulin taxonomic models should be used in clinical guidelines and recommendations rather than restricting ourselves to pharmaceutical-based classifications. PubMed articles including both review articles and clinical trials published since the year 1990 were searched, to gather evidence and information on the various types of insulins available, and how they can be used, based on the number or frequency of injections prescribed per day.
Keywords: Aspart; Basal insulin; BiAsp; Coformulation of insulin; Degludec; Glargine; Glulisine; IDegAsp; IDegLira; Insulin; Intensive insulin; Lispro; LisproMix; LixiLan; Premixed insulin; U300.
Similar articles
-
Flexibility in insulin prescription.Indian J Endocrinol Metab. 2016 May-Jun;20(3):408-11. doi: 10.4103/2230-8210.180003. Indian J Endocrinol Metab. 2016. PMID: 27186563 Free PMC article.
-
Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement.Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):542-5. doi: 10.4103/2230-8210.182980. Indian J Endocrinol Metab. 2016. PMID: 27366723 Free PMC article. Review.
-
Risk stratification of persons on premixed insulin in Ramadan.J Pak Med Assoc. 2017 Nov;67(11):1771-1774. J Pak Med Assoc. 2017. PMID: 29171581
-
Biphasic insulin aspart 30: literature review of adverse events associated with treatment.Clin Ther. 2005;27 Suppl B:S75-88. doi: 10.1016/j.clinthera.2005.11.022. Clin Ther. 2005. PMID: 16519039 Review.
-
Premix insulins in type 1 diabetes: the coming of degludec/aspart.Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):341-348. doi: 10.1080/17425255.2019.1585427. Epub 2019 Mar 18. Expert Opin Drug Metab Toxicol. 2019. PMID: 30789066 Review.
Cited by
-
Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care.Diabetes Ther. 2018 Dec;9(6):2185-2199. doi: 10.1007/s13300-018-0521-2. Epub 2018 Nov 3. Diabetes Ther. 2018. PMID: 30390228 Free PMC article. Review.
-
Flexibility in insulin prescription.Indian J Endocrinol Metab. 2016 May-Jun;20(3):408-11. doi: 10.4103/2230-8210.180003. Indian J Endocrinol Metab. 2016. PMID: 27186563 Free PMC article.
References
-
- Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient centered approach update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140–149. doi: 10.2337/dc14-2441. - DOI - PubMed
-
- Kalra B, Kalra S. Choosing an insulin analogue regime. Internet J Geriatr Gerontol. 2009;5(2). https://ispub.com/IJGG/5/2/11006. Accessed 7 Sep 2015.
-
- Zinman B, Philis-Tsimikas A, Cariou B, Handelsman Y, Rodbard HW, Johansen T, et al. Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long) Diabetes Care. 2012;35(12):2464–2471. doi: 10.2337/dc12-1205. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources